Clinical Trials Directory

Trials / Unknown

UnknownNCT00391495

Inflammation in Children With Attention-Deficit/Hyperactivity Disorder

Status
Unknown
Phase
Study type
Observational
Enrollment
45 (estimated)
Sponsor
Tel-Aviv Sourasky Medical Center · Other Government
Sex
All
Age
9 Years – 13 Years
Healthy volunteers
Accepted

Summary

The aim of this study is to investigate the inflammatory response in children with this disorder.

Detailed description

Attention deficit-hyperactivity disorder (ADHD) is a prevalent childhood neuropsychiatric disorder, characterized by age-inappropriate and impairing levels of inattention, hyperactivity and impulsiveness. Approximately 5-10% of school-age children are affected by ADHD, and in many cases, symptoms persist into adolescence and adulthood. Cytokines are key mediators of immune function and can be either pro-inflammatory or anti-inflammatory. Recently few studies have suggested involvement of cytokine pathways in subjects with ADHD. Polymorphism of IL-1 receptors antagonists' alleles have been suggested in families and subjects suffering from ADHD. Moreover, a new variant of inflammatory bowel disease, another immunological based disease, was recently suggested in children with ADHD and other developmental disorders. There are no other published reports on cytokine production in children who suffer from ADHD.

Conditions

Interventions

TypeNameDescription
PROCEDUREBlood drawing

Timeline

Start date
2007-09-01
Completion
2007-12-01
First posted
2006-10-24
Last updated
2007-06-19

Locations

1 site across 1 country: Israel

Source: ClinicalTrials.gov record NCT00391495. Inclusion in this directory is not an endorsement.